Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in ELDN held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BVF INC/IL | 6.3M | $19.4M | 0.0% | 10.498% | 0.62% |
| 2 | BlackRock, Inc. | 4.4M | $13.5M | +20.8% | 7.310% | 0.00% |
| 3 | Defilade Capital Management, L.P. | 3.6M | $11.0M | +8.3% | 5.945% | 1.54% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 3.3M | $10.1M | — | 5.493% | 0.00% |
| 5 | Ensign Peak Advisors, Inc | 2.5M | $7.6M | 0.0% | 4.112% | 0.01% |
| 6 | Zimmer Partners, LP | 1.9M | $5.8M | -21.4% | 3.128% | 0.14% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.8M | $5.5M | +26.0% | 2.989% | 0.00% |
| 8 | SPHERA FUNDS MANAGEMENT LTD. | 1.8M | $5.5M | -16.9% | 2.956% | 0.91% |
| 9 | Catalio Capital Management, LP | 1.6M | $5.1M | +30.2% | 2.735% | 1.06% |
| 10 | Blue Owl Capital Holdings LP | 1.4M | $4.4M | -26.4% | 2.369% | 1.18% |
| 11 | STATE STREET CORP | 1.2M | $3.6M | +49.2% | 1.926% | 0.00% |
| 12 | AWM Investment Company, Inc. | 1.1M | $3.4M | 0.0% | 1.835% | 0.38% |
| 13 | Jefferies Financial Group Inc. | 1.1M | $3.4M | -30.8% | 1.826% | 0.02% |
| 14 | KINGDON CAPITAL MANAGEMENT, L.L.C. | 1.0M | $3.2M | 0.0% | 1.734% | 0.52% |
| 15 | ADAR1 Capital Management, LLC | 974K | $3.0M | -46.5% | 1.625% | 0.19% |
| 16 | BANK OF AMERICA CORP /DE/ | 870K | $2.7M | +1346.9% | 1.451% | 0.00% |
| 17 | Sanofi | 815K | $2.5M | 0.0% | 1.359% | 0.75% |
| 18 | CM Management, LLC | 650K | $2.0M | 0.0% | 1.084% | 1.67% |
| 19 | 22NW, LP | 636K | $2.0M | 0.0% | 1.061% | 1.34% |
| 20 | UBS Group AG | 547K | $1.7M | -7.7% | 0.913% | 0.00% |
| 21 | NORTHERN TRUST CORP | 544K | $1.7M | +26.5% | 0.907% | 0.00% |
| 22 | VANGUARD FIDUCIARY TRUST CO | 504K | $1.6M | — | 0.840% | 0.00% |
| 23 | VANGUARD PORTFOLIO MANAGEMENT LLC | 430K | $1.3M | — | 0.717% | 0.00% |
| 24 | GOLDMAN SACHS GROUP INC | 370K | $1.1M | +86.2% | 0.617% | 0.00% |
| 25 | Brevan Howard Capital Management LP | 229K | $680K | +16.8% | 0.381% | 0.01% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in ELDN — a direct measure of their conviction.
Filings activity in ELDN during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 118 | +27% | 60.13% | +29.52 pp | $129M | +96% |
| Q4 2025 | 93 | +12% | 30.61% | 13.80 pp | $66M | 31% |
| Q3 2025 | 83 | 3.5% | 44.41% | 7.12 pp | $95M | 14% |
| Q2 2025 | 86 | +3.6% | 51.53% | 8.86 pp | $110M | 15% |
| Q1 2025 | 83 | +11% | 60.39% | 13.03 pp | $129M | 18% |
| Q4 2024 | 75 | +121% | 73.42% | +51.97 pp | $157M | +242% |
| Q3 2024 | 34 | +3.0% | 21.45% | 1.01 pp | $46M | 4.5% |
| Q2 2024 | 33 | — | 22.46% | — | $48M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying ELDN stock.
Based on Q1 2026 13F filings, institutional ownership of Eledon Pharmaceuticals, Inc. stands at 60.1%, held across 118 reporting institutions.
BVF INC/IL is the largest reported institutional holder of ELDN, with approximately 6,293,282 shares worth $0.02B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of ELDN.
Our composite Smart Money Score for ELDN is 57 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
42 institutions opened new positions in ELDN during Q1 2026, while 17 fully exited. 71 added to existing positions and 4 trimmed.
ELDN institutional ownership rose by 29.52 percentage points quarter-over-quarter, with a net change of +25 holders.
The top 10 institutions account for 68.2% of all reported 13F value in ELDN, and the top 25 account for 94.4%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Eledon Pharmaceuticals, Inc. (ELDN) Institutional Ownership